Rusakov IG - Search Results

1

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.

Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB, Zabolotneva AA, Shegay PV, Sokov DG, Gaifullin NM, Rusakov IG, Aliper AM, Roumiantsev SA, Alekseev BY, Borisov NM, Buzdin AA. Lezhnina K, et al. Among authors: rusakov ig. Oncotarget. 2014 Oct 15;5(19):9022-32. doi: 10.18632/oncotarget.2493. Oncotarget. 2014. PMID: 25296972 Free PMC article.

2

[The fluorescent hybridization in situ as applied in diagnostics of urinary bladder cancer].

Savostikova MV, Volchenko NN, Rusakov IG, Borisova OV, Golovashchenko MP. Savostikova MV, et al. Among authors: rusakov ig. Klin Lab Diagn. 2011 Aug;(8):38-40. Klin Lab Diagn. 2011. PMID: 22164416 Russian.

3

[Localization of point mutations in the coding part of the VHL gene in clear cell renal cancer].

Mikhaĭlenko DS, Grigor'eva MV, Rusakov IG, Kurynin RV, Popov AM, Peters MV, Matveev VB, Iakovlev ES, Nosov DA, Liubchenko LN, Tiuliandin SA, Strel'nikov VV, Zaletaev DV. Mikhaĭlenko DS, et al. Among authors: rusakov ig. Mol Biol (Mosk). 2012 Jan-Feb;46(1):71-81. Mol Biol (Mosk). 2012. PMID: 22642103 Russian.

4

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Rini BI, et al. Among authors: rusakov ig. Lancet. 2011 Dec 3;378(9807):1931-9. doi: 10.1016/S0140-6736(11)61613-9. Epub 2011 Nov 4. Lancet. 2011. PMID: 22056247 Clinical Trial.

5

[Fluorescent diagnostic methods and superficial cancer of the urinary bladder: current status].

Rusakov IG, Sokolov VV, Bulgakova NN, Ul'ianov RV, Teplov AA. Rusakov IG, et al. Urologiia. 2008 May-Jun;(3):67-8, 70-2. Urologiia. 2008. PMID: 18669353 Review. Russian. No abstract available.

6

[Radioisotope lymphoscintigraphy used for precise diagnosis of metastatic lymph node involvement in localized and locally advanced prostate cancer].

Rusakov IG, Alekseev BIa, Niushko KM, Frank GA, Belova EA, Bespalov PD, Vorob'ëv NV, Poliakov VA. Rusakov IG, et al. Vopr Onkol. 2006;52(6):686-90. Vopr Onkol. 2006. PMID: 17338250 Russian. No abstract available.

7

[Photodynamic therapy of superficial cancer of the urinary bladder to prevent relapse].

Rusakov IG, Sokolov VV, Bystrov AA. Rusakov IG, et al. Vopr Onkol. 2006;52(6):675-9. Vopr Onkol. 2006. PMID: 17338248 Clinical Trial. Russian. No abstract available.

8

[Neoadjuvant hormone therapy with casodex in a dose 150 mg prior to radical prostatectomy in patients with prostatic cancer].

Rusakov IG, Petrov SB, Alekseev BIa, Veliev EI. Rusakov IG, et al. Urologiia. 2004 Jul-Aug;(4):15-9. Urologiia. 2004. PMID: 15457946 Clinical Trial. Russian. No abstract available.

9

[Evaluation of efficacy of cyproterone acetate monotherapy in prostatic cancer].

Gurina LI, Iudin SV, Rusakov IG, Bystrov AA. Gurina LI, et al. Among authors: rusakov ig. Urologiia. 2003 Jul-Aug;(4):25-30. Urologiia. 2003. PMID: 12942722 Clinical Trial. Russian.

10

[Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].

Rusakov IG, Alekseev BIa. Rusakov IG, et al. Urologiia. 2002 Sep-Oct;(5):23-6. Urologiia. 2002. PMID: 12402771 Russian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page